Warning: Xarelto is Unsafe Because of Bleeding Risks Which Have No Antidote Like Other Blood Thinners

Home / xarelto news / Warning: Xarelto is Unsafe Because of Bleeding Risks Which Have No Antidote Like Other Blood Thinners

Recent studies suggest that the anticoagulant medication, Xarelto, is unsafe because of bleeding risks, which have no antidote approved by the FDA to stop the bleeding when it occurs.  Xarelto is a newer anticoagulant drug prescribed for blood clots in patients with a high risk of deep vein thrombosis, pulmonary embolism, and embolic strokes. The drug is marketed as safer and requires less monitoring than older anticoagulants such as warfarin.

However,  unlike warfarin, where vitamin K and plasma are used to reverse the effects, there is no FDA recommended reversal with Xarelto. In absence of an antidote to stop the internal bleeding that is sometimes caused by the medication, doctors report having to resort to emergency treatments in order to prevent serious injury and deaths.  Personal injury lawsuits are being filed against Xarelto’s makers, Johnson & Johnson and Bayer. The lawsuits states that the makers sold an unreasonably dangerous and defective drug while failing to warn consumers and doctors about the risk of irreversible side effects.

In addition to the potential of internal bleeding with no proven way of stopping it, Xarelto has had problems getting FDA approval for expanding the approved usage for the medication. Most recently, the FDA denied Xarelto use for the treatment of acute coronary syndrome. It was the third FDA rejection for expanding the medication’s usage.

If you or a loved one has experienced injuries including internal bleeding, stroke, and death after using Xarelto, contact us at www.xareltoinjurylawyer.com or www.levenstenlawfirm.com, or 1-800-510-1325 for more information on how to protect your rights to compensation.

Related Posts